2-(1-Hydroxethyl)-4,8-dihydrobenzo[1,2-b:5,4-b′]dithiophene-4,8-dione (BTP-11) enhances the ATRA-induced differentiation in human leukemia HL-60 cells

Leukemia Research

Volumn 33, Issue 12, 2009, Pages 1664-1669

  Chen, Chun Jen ^a   Wen, Yen Fang ^b   Huang, Pi Tsan ^b   Hsu, Mei Hua ^a   Lee, Kuo Hsiung ^c   Chen, Mei Hwai ^b   Shin, Wuu Chian ^b   Huang, Li Jiau ^a   Kuo, Sheng Chu ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Taiwan)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

2 (1 Hydroxethyl) 4,8 dihydrobenzo 1,2 b:5,4 b dithiophene 4,8 dione (BTP 11); ATRA; C EBP ; CDK1; Cyclin D; Differentiation; G0 G1 phase arrest; HL 60

Indexed keywords

2 (1 HYDROXYETHYL) 4,8 DIHYDROBENZO[1,2 B:5,4 B']DITHIOPHENE 4,8 DIONE; ANTILEUKEMIC AGENT; CCAAT ENHANCER BINDING PROTEIN EPSILON; CYCLIN D; CYCLIN DEPENDENT KINASE 4; RETINOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL MATURATION; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG STRUCTURE; GRANULOCYTE; HUMAN; HUMAN CELL; LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTIGENS, CD; BLOTTING, WESTERN; CELL DIFFERENTIATION; DRUG SYNERGISM; FLOW CYTOMETRY; G0 PHASE; G1 PHASE; HL-60 CELLS; HUMANS; THIOPHENES; TRETINOIN;

EID: 70249086298     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.02.023     Document Type: Article

References (23)

1. Bruserud O., and Gjertsen B.T. New strategies for the treatment of acute myelogenous leukemia: differentiation induction-present use and future possibilities. Stem Cells 18 3 (2000) 157-165
2. Fenaux P., Chomienne C., and Degos L. All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Haematol 38 1 (2001) 13-25
3. Tallman M.S., Andersen J.W., Schiffer C.A., Appelbaum F.R., Feusner J.H., Ogden A., et al. Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood 95 1 (2000) 90-95
4. Gallagher R.E. Retinoic acid resistance in acute promyelocytic leukemia. Leukemia 16 10 (2002) 1940-1958
5. 3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. PNAS 101 15 (2004) 5328-5335
6. Hassan H.T., Zyada L.E., Ragab M.H., and Rees J.K. New synergistic combinations of differentiation inducing agents in the treatment of acute myeloid leukaemia. Eur J Clin Pharmacol 41 6 (1991) 531-536
7. Kosugi H., Towatari M., Hatano S., Kitamura K., Kiyoi H., Kinoshita T., et al. Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy. Leukemia 13 9 (1999) 1316-1340
8. Kitamura K., Hoshi S., Koike M., Kiyoi H., Saito H., and Naoe T. Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid. Br J Haematol 108 4 (2000) 696-702
9. Gottlicher M., Minucci S., Zhu P., Kramer O.H., Schimpf A., Giavara S., et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20 24 (2001) 6969-6978
10. Chao Y.H., Kuo S.C., Wu C.H., Lee C.Y., Mauger A., Sun I.C., et al. Synthesis and cytotoxicity of 2-acetyl-4,8-dihydrobenzodithiophene-4, 8-dione derivatives. J Med Chem 41 23 (1998) 4658-4661
11. Chao Y.H., Kuo S.C., Ku K., Chiu I.P., Wu C.H., Mauger A., et al. Synthesis and cytotoxicity of methyl-4,8-dihydrobenzo[1,2-b:5,4-b′]dithiophene-4,8-dione derivatives. Bioorg Med Chem 7 6 (1999) 1025-1031
12. Wen Y.F., Lee K.H., Huang P.T., Chen M.H., Shin W.C., Huang L.J., et al. Cell differentiation enhancement by hydrophilic derivatives of 4,8-dihydrobenzo [1,2-b:5,4-b′]dithiophene-4,8-diones in HL-60 leukemia cells. Bioorg Med Chem Lett 17 10 (2007) 2908-2912
13. Hung C.Y., Hsu M.H., Huang L.J., Hwang C.S., Lee O., Wu C.Y., et al. Synthesis of 1-substituted 3-pyridinyl-methylidenylindolin-2-ones and 1-substituted 3-quinolinylmethylidenylindolin-2-ones as the enhancers of ATRA-induced differentiation in HL-60 cells. Bioorg Med Chem 16 (2008) 4222-4232
14. Hsu M.H., Kuo S.C., Chen C.J., Chung J.G., La YYi, and Huang L.J. 1-(3,4-Dimethoxy-phenyl)-3,5-dodecenedione (I6) induces G1 arrest and apoptosis in human promyelocytic leukemia HL-60 cells. Leukemia Res 29 (2005) 1399-1406
15. Chen C.J., Hsu M.H., Huang L.J., Chung J.G., Lee F.Y., and Kuo S.C. Anticancer mechanisms of YC-1 in human nonsmall-cell lung cancer cell line NCI-H226. Biochem Pharmacol 75 (2008) 360-368
16. Brackman D., Lund-Johansen F., and Aarskog D. Expression of leukocyte differentiation antigens during the differentiation of HL-60 cells induced by 1,25-dihydroxyvitamin D3: comparison with the maturation of normal monocytic and granulocytic bone marrow cells. J Leukoc Biol 58 5 (1995) 547-555
17. Hmama Z., Nandan D., Sly L., Knutson K.L., Herrera-Velit P., and Reiner NE. 1 Alpha, 2,5-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex. J Exp Med 190 11 (1999) 1583-1594
18. Walsh K., and Perlman H. Cell cycle exit upon myogenic differentiation. Curr Opin Genet Dev 7 5 (1997) 597-602
19. Jing Y., Wang L., Xia L., Chen G.Q., Chen Z., Miller W.H., et al. Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo. Blood 97 1 (2001) 264-269
20. Ding Q., Jin T., Wang Z., and Chen Y. Catalase potentiates retinoic acid-induced THP-1 monocyte differentiation into macrophage through inhibition of peroxisome proliferator-activated receptor gamma. J Leukoc Biol 81 6 (2007) 1568-1576
21. Park D.J., Chumakov A.M., Vuong P.T., Chih D.Y., Gombart A.F., Miller Jr. W.H., et al. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. J Clin Invest 103 10 (1999) 1399-1408
22. Lekstrom-Himes J.A. The role of C/EBP(epsilon) in the terminal stages of granulocyte differentiation. Stem Cells 19 2 (2001) 125-133
23. Truong B.T., Lee Y.J., Lodie T.A., Park D.J., Perrotti D., Watanabe N., et al. CCAAT/enhancer binding proteins repress the leukemic phenotype of acute myeloidn leukemia. Blood 101 3 (2003) 1141-1148